In conclusion, our study enhances the understanding of the molecular mechanism underlying ETV6/RUNX1-mediated attenuation of B-cell differentiation and offers the opportunity to identify new targets for development of therapeutic approaches to leukemia. The gene discussed is ETV6; the disease is leukemia.